Cardiogenic shock — the current state of the problem

Abstract

Today the incidence of cardiogenic shock (CS) among the patients with myocardial infarction (MI) is on average in 7-8%. Despite the fact that CS is not the most frequent complication of MI, it is the most common cause of death in this disease. The standard and new perspective treatment approaches are being reviewed in this article with emphasis on the method of mechanical circulatory support (MCS). According to a data from large registries, a new approach of utilization of contemporary MCS devices has demonstrated its efficiency in reducing mortality in the patients with MI complicated by CS. At the present stage, universal treatment protocols for CS are being designed. The central element of these protocols is MCS with the use of contemporary devices, implemented according to a scheme that has demonstrated its effectiveness.

Keywords

• cardiogenic shock
• myocardial infarction
• mechanical circulatory support
• iabp
• impella
• ecmo